LUMAKRAS

Amgen Inc.

Application Filed: 2020-07-09
Trademark Application Details
Trademark Logo LUMAKRAS

Mark For: LUMAKRAS® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders. [all]

Status

2021-05-28 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Website www.amgen.com whois domain owner info
Research OneLook Acronym Finder
Serial Number90044720
Registration Number6487719
Mark Literal ElementsLUMAKRAS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-11-24
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameElsa D. Lemoine
Attorney Docket NumberTM-2089-US-1

Timeline

2020-07-09Application Filed
2020-07-13Location: NEW APPLICATION PROCESSING
2020-07-13Status: Live/Pending
2020-07-13Transaction Date
2020-09-29Published
2020-11-24Location: INTENT TO USE SECTION
2021-04-02Status: A first request for extension of time to file a Statement of Use has been granted.
2021-09-14Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Amgen Inc.
AddressTrademark Operations - MS-28-5A One Amgen Center Drive Thousand Oaks, CALIFORNIA UNITED STATES 913201799
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

ELSA D. LEMOINE
AMGEN INC.
ONE AMGEN CENTER DRIVE
TRADEMARK OPERATIONS-MS-28-5A
THOUSAND OAKS, CA 91320-1799

Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: pharmaceutical preparations for use in the treatment of cancer. FIRST USE: 20210603. FIRST USE IN COMMERCE: 20210603

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
GS0051pharmaceutical preparations for use in the treatment of cancer

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2021-09-14
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2021-08-07
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2021-08-06
STATEMENT OF USE PROCESSING COMPLETE2021-07-1366230
CASE ASSIGNED TO INTENT TO USE PARALEGAL2021-07-1266230
USE AMENDMENT FILED2021-06-3066230
TEAS STATEMENT OF USE RECEIVED2021-06-30
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-04-06
TEAS EXTENSION RECEIVED2021-04-02
SOU EXTENSION 1 GRANTED2021-04-0298765
SOU EXTENSION 1 FILED2021-04-0298765
EXTENSION 1 GRANTED2021-04-0298765
EXTENSION 1 FILED2021-04-0298765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-11-24
PUBLISHED FOR OPPOSITION2020-09-29
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-09-29
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-09-09
APPROVED FOR PUB - PRINCIPAL REGISTER2020-08-21
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2020-08-206328
EXAMINERS AMENDMENT E-MAILED2020-08-206328
EXAMINERS AMENDMENT -WRITTEN2020-08-2094491
EXAMINER'S AMENDMENT ENTERED2020-08-2088888
ASSIGNED TO EXAMINER2020-08-1794491
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-08-05
NEW APPLICATION ENTERED IN TRAM2020-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed